Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 6Terminated 4Unknown 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Hematologic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Leukemia, Myeloid, Acute 3beta-Thalassemia 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Graft vs Host Disease 2Anemia, Refractory, with Excess of Blasts 2Virus Diseases 1Thalassemia 1Primary Myelofibrosis 1Non-Malignant Neoplasm 1Neurofibromatosis 1 1Neoplasm, Residual 1Myeloproliferative Disorders 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, B-Cell 1Influenza, Human 1Fanconi Anemia 1Cytopenia 1Chromosome Aberrations 1Chromosome 7, monosomy 1Anemia, Sickle Cell 1

Interventions

Cyclophosphamide 10fludarabine 6Tacrolimus 5Mycophenolic Acid 5Melphalan 4ruxolitinib 3Whole-Body Irradiation 3Thiotepa 3Busulfan 3thymoglobulin 2fludarabine phosphate 2Stem Cell Transplantation 2Specimen Handling 2Clofarabine 2Biopsy 2vedolizumab 1belumosudil 1Tomography, Optical Coherence 1Sirolimus 1Radiotherapy 1Radiation 1Prednisone 1Methotrexate 1Mesna 1Low-Level Light Therapy 1LDP-02 1Immunoglobulin G 1Hematopoietic Stem Cell Transplantation 1Fecal Microbiota Transplantation 1Emapalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Graft vs Host Disease × thymoglobulin × Clear all
NCT03852407 2022-10-12

HLA

University of Liege

Phase 2 Recruiting
114 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, B-Cell, Hematologic Neoplasms

NCT03818334 2019-02-01

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Hospital Israelita Albert Einstein

Phase 2/3 Recruiting
50 enrolled
Other hematologic neoplasm

Graft vs Host Disease, Virus Diseases, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡